Literature DB >> 4729052

The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.

A P Kaplan, E J Goetzl, K F Austen.   

Abstract

The conversion of plasminogen proactivator to plasminogen activator by Hageman factor fragments results in the generation of chemotactic activity for human neutrophils. This chemotactic activity can be distinguished from that generated by Hageman factor activation of prekallikrein and is demonstrable in plasma that is genetically deficient in prekallikrein (Fletcher factor deficiency). Both the plasminogen-activating activity and chemotactic activity produced by the interaction of Hageman factor fragments and plasminogen proactivator to yield plasminogen activator were inhibited by diisopropyl fluorophosphate (DFP) indicating an essential role for the enzymatic site in both these activities. The finding that the plasminogen proactivator tolerated a dose of DFP, which completely inactivated the plasminogen activator, reveals that the active site is protected in the precursor protein.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729052      PMCID: PMC302519          DOI: 10.1172/JCI107451

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  The inhibition of plasmin by toxic phosphorus compounds.

Authors:  L A MOUNTER; B A SHIPLEY
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

2.  Stoichiometric inhibition of chymotrypsin.

Authors:  A K BALLS; E F JANSEN
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1952

3.  Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

4.  The relation of 'Fletcher Factor' to factors XI and XII.

Authors:  W E Hathaway; J Alsever
Journal:  Br J Haematol       Date:  1970-02       Impact factor: 6.998

5.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

6.  A pre-albumin activator of prekallikrein.

Authors:  A P Kaplan; K F Austen
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

7.  Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties.

Authors:  W E Hathaway; L P Belhasen; H S Hathaway
Journal:  Blood       Date:  1965-11       Impact factor: 22.113

8.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

9.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

10.  The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  12 in total

1.  Neutrophil function and host resistance.

Authors:  B Zakhireh; L H Block; R K Root
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 2.  Leukotaxis and leukotactic disorders. A review.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

Review 3.  Modulation of human eosinophil polymorphonuclear leukocyte migration and function.

Authors:  E J Goetzl
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

Review 4.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

Review 5.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

6.  Platelet factor 4 is chemotactic for neutrophils and monocytes.

Authors:  T F Deuel; R M Senior; D Chang; G L Griffin; R L Heinrikson; E T Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.

Authors:  R A Patrick; J C Hollers; D Y Liu; B H Giese; C W Smith
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition.

Authors:  D E Epps; R C Williams
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

9.  Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge.

Authors:  J I Gallin; J R Durocher; A P Kaplan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  A phagocytosis-enhancing factor in human plasma.

Authors:  I Gigli; B U Wintroub; E J Goetzl
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.